商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
QUETIAPINE FUMARATE | 205983 | 001 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 25MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 205983 | 002 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 50MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 205983 | 003 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 100MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 205983 | 004 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 200MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 205983 | 005 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 300MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 205983 | 006 | ANDA | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 400MG BASE | No | No | 2024/05/20 | 2024/05/20 | IPCA LABS LTD | Prescription |
QUETIAPINE FUMARATE | 211144 | 001 | ANDA | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | No | No | 2024/11/26 | 2024/11/26 | GRAVITI PHARMS | Prescription |
QUETIAPINE FUMARATE | 211144 | 002 | ANDA | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 150MG BASE | No | No | 2024/11/26 | 2024/11/26 | GRAVITI PHARMS | Prescription |
QUETIAPINE FUMARATE | 211144 | 003 | ANDA | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG BASE | No | No | 2024/11/26 | 2024/11/26 | GRAVITI PHARMS | Prescription |
QUETIAPINE FUMARATE | 211144 | 004 | ANDA | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 300MG BASE | No | No | 2024/11/26 | 2024/11/26 | GRAVITI PHARMS | Prescription |
QUETIAPINE FUMARATE | 211144 | 005 | ANDA | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 400MG BASE | No | No | 2024/11/26 | 2024/11/26 | GRAVITI PHARMS | Prescription |